Ja H. Yeo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
EpCAM+ Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 14, 2026
Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure.
Journal: Therapeutic advances in medical oncology
Published: December 04, 2025
Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 03, 2025
Sarcopenia Predicts Outcome After Chemoimmunotherapy, Not Chemotherapy, in Advanced Lung Cancer: Single-Centre Retrospective Study.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 04, 2025
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis.
Journal: American journal of clinical oncology
Published: January 06, 2022
Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.
Journal: American journal of clinical oncology
Published: March 12, 2021
Portal vein stent for symptomatic malignant portal vein stenosis: A single-center experience.
Journal: Current problems in cancer
Published: March 23, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026